LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, and Rising Tide Foundation for Clinical Cancer Research (RTFCCR) announced a joint call for research proposals ...
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of reirradiation using ...
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University College London, ...
Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...
Our scalable NLP system enabled us to generate real-world insights into NSCLC recurrences, paving the way for predictive models for preventing, diagnosing, and treating NSCLC recurrence. Our NLP ...
PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...
Established recommended Phase 2 dose of NBTXR3 for the treatment of patients with inoperable, recurrent non-small cell lung cancer (“NSCLC”) who have previously received definitive radiation therapy ...
An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research ...
Dr. K. K. Pandey In the Indian subcontinent, individuals of all ages suffer from cough at various stages of life. With the ...
Results demonstrate the importance of ultra-sensitive ctDNA detection in lung cancer In this study, NeXT Personal was used to analyze pre-operative blood samples from a TRACERx cohort of 171 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results